Skip to main content
Erschienen in: Inflammation 5/2012

01.10.2012

The Transcription Levels of ABCA1, ABCG1 and SR-BI are Negatively Associated with Plasma CRP in Chinese Populations with Various Risk Factors for Atherosclerosis

verfasst von: Chengjiang Li, Renyong Guo, Juanya Lou, Huali Zhou

Erschienen in: Inflammation | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Abstract

ATP binding cassette transporters (ABCA1, ABCG1) and scavenger receptor class B type I (SR-BI) are the three most important cellular cholesterol transporters that may prevent atherogenesis. The aim of this study was to investigate whether they were altered in Chinese populations with various risk factors for atherosclerosis and their potential associations with C-reactive protein (CRP). Healthy female controls (n = 30) and populations with various risk factors for atherosclerosis, such as type 2 diabetes (n = 17), hypertension (n = 12), overweight/obesity (n = 10), incipient nephropathy (n = 10), postmenopausal women (n = 9), male (n = 19), ageing male (n = 22), or smoking (n = 16), were recruited. ABCA1, ABCG1 and SR-BI mRNA levels in peripheral monocytes was determined. ABCG1 was decreased in all the risk populations except ageing. ABCA1 was decreased in all the risk populations except diabetes and male. SR-BI was decreased in those with overweight/obesity and incipient nephropathy. Circulating CRP was increased almost in all the risk populations except in males. The levels of ABCA1, ABCG1 and SR-BI were reduced in those with subclinically high CRP, and negatively associated with CRP level. These data indicates that ABCA1, ABCG1, and SR-BI are reduced in various populations under subclinically inflammatory conditions, which may potentially lead to impairing reverse cholesterol transport and developing atherosclerosis.
Literatur
1.
Zurück zum Zitat Lewis, G.F., and D.J. Rader. 2005. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circulation Research 96: 1221–1232.PubMedCrossRef Lewis, G.F., and D.J. Rader. 2005. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circulation Research 96: 1221–1232.PubMedCrossRef
2.
Zurück zum Zitat Jessup, W., I.C. Gelissen, K. Gaus, and L. Kritharides. 2006. Roles of ATP binding cassette transporters A1 and G1, scavenger receptor BI and membrane lipid domains in cholesterol export from macrophages. Current Opinion in Lipidology 17: 247–257.PubMedCrossRef Jessup, W., I.C. Gelissen, K. Gaus, and L. Kritharides. 2006. Roles of ATP binding cassette transporters A1 and G1, scavenger receptor BI and membrane lipid domains in cholesterol export from macrophages. Current Opinion in Lipidology 17: 247–257.PubMedCrossRef
3.
Zurück zum Zitat Van Eck, M., M. Pennings, M. Hoekstra, R. Out, and T.J. Van Berkel. 2005. Scavenger receptor BI and ATP-binding cassette transporter A1 in reverse cholesterol transport and atherosclerosis. Current Opinion in Lipidology 16: 307–315.PubMedCrossRef Van Eck, M., M. Pennings, M. Hoekstra, R. Out, and T.J. Van Berkel. 2005. Scavenger receptor BI and ATP-binding cassette transporter A1 in reverse cholesterol transport and atherosclerosis. Current Opinion in Lipidology 16: 307–315.PubMedCrossRef
4.
Zurück zum Zitat Zhou, H., K.C. Tan, S.W. Shiu, and Y. Wong. 2008. Determinants of leukocyte adenosine triphosphate-binding cassette transporter G1 gene expression in type 2 diabetes mellitus. Metabolism 57: 1135–1140.PubMedCrossRef Zhou, H., K.C. Tan, S.W. Shiu, and Y. Wong. 2008. Determinants of leukocyte adenosine triphosphate-binding cassette transporter G1 gene expression in type 2 diabetes mellitus. Metabolism 57: 1135–1140.PubMedCrossRef
5.
Zurück zum Zitat Wang, X., H.L. Collins, M. Ranalletta, I.V. Fuki, J.T. Billheimer, G.H. Rothblat, A.R. Tall, and D.J. Rader. 2007. Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo. Journal of Clinical Investigation 117: 2216–2224.PubMedCrossRef Wang, X., H.L. Collins, M. Ranalletta, I.V. Fuki, J.T. Billheimer, G.H. Rothblat, A.R. Tall, and D.J. Rader. 2007. Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo. Journal of Clinical Investigation 117: 2216–2224.PubMedCrossRef
6.
Zurück zum Zitat Schou, J., R. Frikke-Schmidt, D. Kardassis, E. Thymiakou, B.G. Nordestgaard, G. Jensen, P. Grande, and A. Tybjærg-Hansen. 2012. Genetic variation in ABCG1 and risk of myocardial infarction and ischemic heart disease. Arteriosclerosis, Thrombosis, and Vascular Biology 32: 506–515.PubMedCrossRef Schou, J., R. Frikke-Schmidt, D. Kardassis, E. Thymiakou, B.G. Nordestgaard, G. Jensen, P. Grande, and A. Tybjærg-Hansen. 2012. Genetic variation in ABCG1 and risk of myocardial infarction and ischemic heart disease. Arteriosclerosis, Thrombosis, and Vascular Biology 32: 506–515.PubMedCrossRef
7.
Zurück zum Zitat Regieli, J.J., P.A. Doevendans, D.E. Grobbee, A.H. Zwinderman, Y. van der Graaf, J.J. Kastelein, and J.W. Jukema. 2011. ABCA1 impacts athero-thrombotic risk and 10-year survival in a contemporary secondary prevention setting. Atherosclerosis 218: 457–463.PubMedCrossRef Regieli, J.J., P.A. Doevendans, D.E. Grobbee, A.H. Zwinderman, Y. van der Graaf, J.J. Kastelein, and J.W. Jukema. 2011. ABCA1 impacts athero-thrombotic risk and 10-year survival in a contemporary secondary prevention setting. Atherosclerosis 218: 457–463.PubMedCrossRef
8.
Zurück zum Zitat Xu, Y., W. Wang, L. Zhang, L.P. Qi, L.Y. Li, L.F. Chen, Q. Fang, A.M. Dang, and X.W. Yan. 2011. A polymorphism in the ABCG1 promoter is functionally associated with coronary artery disease in a Chinese Han population. Atherosclerosis 219: 648–654.PubMedCrossRef Xu, Y., W. Wang, L. Zhang, L.P. Qi, L.Y. Li, L.F. Chen, Q. Fang, A.M. Dang, and X.W. Yan. 2011. A polymorphism in the ABCG1 promoter is functionally associated with coronary artery disease in a Chinese Han population. Atherosclerosis 219: 648–654.PubMedCrossRef
9.
Zurück zum Zitat Xu, M., H. Zhou, Q. Gu, and C. Li. 2009. The expression of ATP-binding cassette transporters in hypertensive patients. Hypertension Research 32: 455–461.PubMedCrossRef Xu, M., H. Zhou, Q. Gu, and C. Li. 2009. The expression of ATP-binding cassette transporters in hypertensive patients. Hypertension Research 32: 455–461.PubMedCrossRef
10.
Zurück zum Zitat Xu, M., H. Zhou, J. Wang, C. Li, and Y. Yu. 2009. The expression of ATP-binding cassette transporter A1 in Chinese overweight and obese patients. International Journal of Obesity 33: 851–856.PubMedCrossRef Xu, M., H. Zhou, J. Wang, C. Li, and Y. Yu. 2009. The expression of ATP-binding cassette transporter A1 in Chinese overweight and obese patients. International Journal of Obesity 33: 851–856.PubMedCrossRef
11.
Zurück zum Zitat Forcheron, F., A. Cachefo, S. Thevenon, C. Pinteur, and M. Beylot. 2002. Mechanisms of the triglyceride- and cholesterol-lowering effect of fenofibrate in hyperlipidemic type 2 diabetic patients. Diabetes 51: 3486–3491.PubMedCrossRef Forcheron, F., A. Cachefo, S. Thevenon, C. Pinteur, and M. Beylot. 2002. Mechanisms of the triglyceride- and cholesterol-lowering effect of fenofibrate in hyperlipidemic type 2 diabetic patients. Diabetes 51: 3486–3491.PubMedCrossRef
12.
Zurück zum Zitat Mauldin, J.P., M.H. Nagelin, A.J. Wojcik, S. Srinivasan, M.D. Skaflen, C.R. Ayers, C.A. McNamara, and C.C. Hedrick. 2008. Reduced expression of ATP-binding cassette transporter G1 increases cholesterol accumulation in macrophages of patients with type 2 diabetes mellitus. Circulation 117: 2785–2792.PubMedCrossRef Mauldin, J.P., M.H. Nagelin, A.J. Wojcik, S. Srinivasan, M.D. Skaflen, C.R. Ayers, C.A. McNamara, and C.C. Hedrick. 2008. Reduced expression of ATP-binding cassette transporter G1 increases cholesterol accumulation in macrophages of patients with type 2 diabetes mellitus. Circulation 117: 2785–2792.PubMedCrossRef
13.
Zurück zum Zitat Ovbiagele, B. 2008. Microalbuminuria: Risk factor and potential therapeutic target for stroke? Journal of the Neurological Sciences 271: 21–28.PubMedCrossRef Ovbiagele, B. 2008. Microalbuminuria: Risk factor and potential therapeutic target for stroke? Journal of the Neurological Sciences 271: 21–28.PubMedCrossRef
14.
Zurück zum Zitat Bakker, S.J., R.T. Gansevoort, E.M. Stuveling, R.O. Gans, and D. de Zeeuw. 2005. Microalbuminuria and C-reactive protein: Similar messengers of cardiovascular risk? Current Hypertension Reports 7: 379–384.PubMedCrossRef Bakker, S.J., R.T. Gansevoort, E.M. Stuveling, R.O. Gans, and D. de Zeeuw. 2005. Microalbuminuria and C-reactive protein: Similar messengers of cardiovascular risk? Current Hypertension Reports 7: 379–384.PubMedCrossRef
15.
Zurück zum Zitat Fitzgerald, M.L., Z. Mujawar, and N. Tamehiro. 2010. ABC transporters, atherosclerosis and inflammation. Atherosclerosis 211: 361–370.PubMedCrossRef Fitzgerald, M.L., Z. Mujawar, and N. Tamehiro. 2010. ABC transporters, atherosclerosis and inflammation. Atherosclerosis 211: 361–370.PubMedCrossRef
16.
Zurück zum Zitat Pagler, T.A., M. Wang, M. Mondal, A.J. Murphy, M. Westerterp, K.J. Moore, F.R. Maxfield, and A.R. Tall. 2011. Deletion of ABCA1 and ABCG1 impairs macrophage migration because of increased Rac1 signaling. Circulation Research 108: 194–200.PubMedCrossRef Pagler, T.A., M. Wang, M. Mondal, A.J. Murphy, M. Westerterp, K.J. Moore, F.R. Maxfield, and A.R. Tall. 2011. Deletion of ABCA1 and ABCG1 impairs macrophage migration because of increased Rac1 signaling. Circulation Research 108: 194–200.PubMedCrossRef
17.
Zurück zum Zitat Calabrò, P., E. Golia, and E.T. Yeh. 2009. CRP and the risk of atherosclerotic events. Seminars in Immunopathology 31: 79–94.PubMedCrossRef Calabrò, P., E. Golia, and E.T. Yeh. 2009. CRP and the risk of atherosclerotic events. Seminars in Immunopathology 31: 79–94.PubMedCrossRef
18.
Zurück zum Zitat Tan, K.C., S.W. Shiu, Y. Wong, and S. Tam. 2005. Plasma phospholipid transfer protein activity and subclinical inflammation in type 2 diabetes mellitus. Atherosclerosis 178: 365–370.PubMedCrossRef Tan, K.C., S.W. Shiu, Y. Wong, and S. Tam. 2005. Plasma phospholipid transfer protein activity and subclinical inflammation in type 2 diabetes mellitus. Atherosclerosis 178: 365–370.PubMedCrossRef
19.
Zurück zum Zitat Soriano-Guillén, L., B. Hernández-García, J. Pita, N. Domínguez-Garrido, G. Del Río-Camacho, and A. Rovira. 2008. High-sensitivity C-reactive protein is a good marker of cardiovascular risk in obese children and adolescents. European Journal of Endocrinology 159: R1–R4.PubMedCrossRef Soriano-Guillén, L., B. Hernández-García, J. Pita, N. Domínguez-Garrido, G. Del Río-Camacho, and A. Rovira. 2008. High-sensitivity C-reactive protein is a good marker of cardiovascular risk in obese children and adolescents. European Journal of Endocrinology 159: R1–R4.PubMedCrossRef
20.
Zurück zum Zitat Rizzo, M., E. Corrado, G. Coppola, I. Muratori, A. Mezzani, G. Novo, and S. Novo. 2009. The predictive role of C-reactive protein in patients with hypertension and subclinical atherosclerosis. Internal Medicine Journal 39: 539–545.PubMedCrossRef Rizzo, M., E. Corrado, G. Coppola, I. Muratori, A. Mezzani, G. Novo, and S. Novo. 2009. The predictive role of C-reactive protein in patients with hypertension and subclinical atherosclerosis. Internal Medicine Journal 39: 539–545.PubMedCrossRef
21.
Zurück zum Zitat Wang, X., D. Liao, U. Bharadwaj, M. Li, Q. Yao, and C. Chen. 2008. C-reactive protein inhibits cholesterol efflux from human macrophage-derived foam cells. Arteriosclerosis, Thrombosis, and Vascular Biology 28: 519–526.PubMedCrossRef Wang, X., D. Liao, U. Bharadwaj, M. Li, Q. Yao, and C. Chen. 2008. C-reactive protein inhibits cholesterol efflux from human macrophage-derived foam cells. Arteriosclerosis, Thrombosis, and Vascular Biology 28: 519–526.PubMedCrossRef
22.
Zurück zum Zitat Xu, M., H. Zhou, K.C. Tan, R. Guo, S.W. Shiu, and Y. Wong. 2009. ABCG1 mediated oxidized LDL-derived oxysterol efflux from macrophages. Biochemical and Biophysical Research Communications 390: 1349–1354.PubMedCrossRef Xu, M., H. Zhou, K.C. Tan, R. Guo, S.W. Shiu, and Y. Wong. 2009. ABCG1 mediated oxidized LDL-derived oxysterol efflux from macrophages. Biochemical and Biophysical Research Communications 390: 1349–1354.PubMedCrossRef
23.
Zurück zum Zitat Meurs, I., B. Lammers, Y. Zhao, R. Out, R.B. Hildebrand, M. Hoekstra, T.J. Van Berkel, and M. Van Eck. 2012. The effect of ABCG1 deficiency on atherosclerotic lesion development in LDL receptor knockout mice depends on the stage of atherogenesis. Atherosclerosis 221: 41–47.PubMedCrossRef Meurs, I., B. Lammers, Y. Zhao, R. Out, R.B. Hildebrand, M. Hoekstra, T.J. Van Berkel, and M. Van Eck. 2012. The effect of ABCG1 deficiency on atherosclerotic lesion development in LDL receptor knockout mice depends on the stage of atherogenesis. Atherosclerosis 221: 41–47.PubMedCrossRef
24.
Zurück zum Zitat Isoda, K., E.J. Folco, K. Shimizu, and P. Libby. 2007. AGE-BSA decreases ABCG1 expression and reduces macrophage cholesterol efflux to HDL. Atherosclerosis 192: 298–304.PubMedCrossRef Isoda, K., E.J. Folco, K. Shimizu, and P. Libby. 2007. AGE-BSA decreases ABCG1 expression and reduces macrophage cholesterol efflux to HDL. Atherosclerosis 192: 298–304.PubMedCrossRef
25.
Zurück zum Zitat Tan, K.C., W.S. Chow, S. Tam, R. Bucala, and J. Betteridge. 2004. Association between acute-phase reactants and advanced glycation end products in type 2 diabetes. Diabetes Care 27: 223–228.PubMedCrossRef Tan, K.C., W.S. Chow, S. Tam, R. Bucala, and J. Betteridge. 2004. Association between acute-phase reactants and advanced glycation end products in type 2 diabetes. Diabetes Care 27: 223–228.PubMedCrossRef
26.
Zurück zum Zitat Zhong, Y., S.H. Li, S.M. Liu, P.E. Szmitko, X.Q. He, P.W. Fedak, and S. Verma. 2006. C-Reactive protein upregulates receptor for advanced glycation end products expression in human endothelial cells. Hypertension 48: 504–511.PubMedCrossRef Zhong, Y., S.H. Li, S.M. Liu, P.E. Szmitko, X.Q. He, P.W. Fedak, and S. Verma. 2006. C-Reactive protein upregulates receptor for advanced glycation end products expression in human endothelial cells. Hypertension 48: 504–511.PubMedCrossRef
27.
Zurück zum Zitat Singh, R., A. Barden, T. Mori, and L. Beilin. 2001. Advanced glycation end-products: A review. Diabetologia 44: 129–146.PubMedCrossRef Singh, R., A. Barden, T. Mori, and L. Beilin. 2001. Advanced glycation end-products: A review. Diabetologia 44: 129–146.PubMedCrossRef
28.
Zurück zum Zitat Cerami, C., H. Founds, I. Nicholl, T. Mitsuhashi, D. Giordano, S. Vanpatten, A. Lee, Y. Al-Abed, H. Vlassara, R. Bucala, and A. Cerami. 1997. Tobacco smoke is a source of toxic reactive glycation products. Proceedings of the National Academy of Sciences of the United States of America 94: 13915–13920.PubMedCrossRef Cerami, C., H. Founds, I. Nicholl, T. Mitsuhashi, D. Giordano, S. Vanpatten, A. Lee, Y. Al-Abed, H. Vlassara, R. Bucala, and A. Cerami. 1997. Tobacco smoke is a source of toxic reactive glycation products. Proceedings of the National Academy of Sciences of the United States of America 94: 13915–13920.PubMedCrossRef
29.
Zurück zum Zitat Wander, K., E. Brindle, and K.A. O’Connor. 2008. C-reactive protein across the menstrual cycle. American Journal of Physical Anthropology 136: 138–146.PubMedCrossRef Wander, K., E. Brindle, and K.A. O’Connor. 2008. C-reactive protein across the menstrual cycle. American Journal of Physical Anthropology 136: 138–146.PubMedCrossRef
30.
Zurück zum Zitat Vitale, C., M.E. Mendelsohn, and G.M. Rosano. 2009. Gender differences in the cardiovascular effect of sex hormones. Nature Reviews Cardiology 6: 532–542.PubMedCrossRef Vitale, C., M.E. Mendelsohn, and G.M. Rosano. 2009. Gender differences in the cardiovascular effect of sex hormones. Nature Reviews Cardiology 6: 532–542.PubMedCrossRef
31.
Zurück zum Zitat Langmann, T., J. Klucken, M. Reil, G. Liebisch, M.F. Luciani, G. Chimini, W.E. Kaminski, and G. Schmitz. 1999. Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): Evidence for sterol-dependent regulation in macrophages. Biochemical and Biophysical Research Communications 257: 29–33.PubMedCrossRef Langmann, T., J. Klucken, M. Reil, G. Liebisch, M.F. Luciani, G. Chimini, W.E. Kaminski, and G. Schmitz. 1999. Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): Evidence for sterol-dependent regulation in macrophages. Biochemical and Biophysical Research Communications 257: 29–33.PubMedCrossRef
32.
Zurück zum Zitat Klucken, J., C. Büchler, E. Orsó, W.E. Kaminski, M. Porsch-Ozcürümez, G. Liebisch, M. Kapinsky, W. Diederich, W. Drobnik, M. Dean, R. Allikmets, and G. Schmitz. 2000. ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport. Proceedings of the National Academy of Sciences of the United States of America 97: 817–822.PubMedCrossRef Klucken, J., C. Büchler, E. Orsó, W.E. Kaminski, M. Porsch-Ozcürümez, G. Liebisch, M. Kapinsky, W. Diederich, W. Drobnik, M. Dean, R. Allikmets, and G. Schmitz. 2000. ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport. Proceedings of the National Academy of Sciences of the United States of America 97: 817–822.PubMedCrossRef
33.
Zurück zum Zitat Han, J., A.C. Nicholson, X. Zhou, J. Feng, A.M. Gotto Jr., and D.P. Hajjar. 2001. Oxidized low density lipoprotein decreases macrophage expression of scavenger receptor B-I. Journal of Biological Chemistry 276: 16567–16572.PubMedCrossRef Han, J., A.C. Nicholson, X. Zhou, J. Feng, A.M. Gotto Jr., and D.P. Hajjar. 2001. Oxidized low density lipoprotein decreases macrophage expression of scavenger receptor B-I. Journal of Biological Chemistry 276: 16567–16572.PubMedCrossRef
Metadaten
Titel
The Transcription Levels of ABCA1, ABCG1 and SR-BI are Negatively Associated with Plasma CRP in Chinese Populations with Various Risk Factors for Atherosclerosis
verfasst von
Chengjiang Li
Renyong Guo
Juanya Lou
Huali Zhou
Publikationsdatum
01.10.2012
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 5/2012
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-012-9479-9

Weitere Artikel der Ausgabe 5/2012

Inflammation 5/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.